Articles
Doctors reach online tipping point: is pharma ready to respond?

Doctors reach online tipping point: is pharma ready to respo...

Carwyn Jones, Head of Pharmaceutical at Doctors.net.uk, reveals opportunities for a step-change in online engagement with medical professionals. Online engagement, in all its forms, can no longer be regarded as the preserve of the ‘early adopters’ or those with an addiction to Facebook, Bebo and Twitter...

Articles
Unifying the prescriber influence network (part I)

Unifying the prescriber influence network (part I)

In the first of a two part series, Cisco and Exploria review the challenges to pharma promotion as influence networks grow ever more complex. Part II will be published on Thursday 22nd October. The pharmaceutical marketplace has changed dramatically over the past decade, yet the industry’s sales model remains much the same. Most pharmaceutical companies still rely on an army of sales representatives to promote their products to physicians...

Articles
Is REMS the new market access moderator?

Is REMS the new market access moderator?

As market access for US medicines comes under scrutiny, Jeff Fetterman provides an expert perspective on the challenges of Risk Evaluation and Management Strategies (REMS). The path to regulatory approval in the United States has always been riddled with setbacks, surprises, and last-second modifications…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more